House
File
448
-
Introduced
HOUSE
FILE
448
BY
SUNDE
A
BILL
FOR
An
Act
relating
to
the
dispensing
of
self-administered
hormonal
1
contraceptives
pursuant
to
a
prescription
and
providing
for
2
insurance
coverage.
3
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
4
TLSB
2340HH
(4)
89
pf/rh
H.F.
448
Section
1.
Section
155A.3,
Code
2021,
is
amended
by
adding
1
the
following
new
subsections:
2
NEW
SUBSECTION
.
18A.
“Generic”
means
a
chemically
3
equivalent
copy
of
a
brand-name
drug
with
an
expired
patent.
4
NEW
SUBSECTION
.
44A.
“Self-administered
hormonal
5
contraceptive”
means
a
self-administered
hormonal
contraceptive
6
that
is
approved
by
the
United
States
food
and
drug
7
administration
to
prevent
pregnancy.
8
Sec.
2.
NEW
SECTION
.
155A.47
Pharmacist
dispensing
of
9
self-administered
hormonal
contraceptives
——
limitations
of
10
liability.
11
1.
Notwithstanding
any
provision
of
law
to
the
contrary,
12
a
pharmacist
may
dispense
a
self-administered
hormonal
13
contraceptive
to
a
patient
pursuant
to
a
prescription
in
14
accordance
with
the
following:
15
a.
For
an
initial
dispensing
of
a
self-administered
16
hormonal
contraceptive,
the
pharmacist
may
dispense
only
up
17
to
a
three-month
supply
at
one
time
of
the
self-administered
18
hormonal
contraceptive.
19
b.
For
any
subsequent
dispensing
of
the
same
20
self-administered
hormonal
contraceptive,
the
pharmacist
21
may
dispense
up
to
a
twelve-month
supply
at
one
time
22
of
the
self-administered
hormonal
contraceptive.
For
23
the
purposes
of
this
paragraph,
subsequent
dispensing
24
of
the
same
self-administered
hormonal
contraceptive
25
includes
the
subsequent
dispensing
of
a
generic
form
of
26
self-administered
hormonal
contraceptive
in
place
of
a
27
brand-name
self-administered
hormonal
contraceptive.
28
2.
A
pharmacist
who
dispenses
a
self-administered
hormonal
29
contraceptive
in
compliance
with
this
section
shall
be
30
immune
from
criminal
and
civil
liability
arising
from
any
31
damages
caused
by
the
dispensing,
administering,
or
use
of
a
32
self-administered
hormonal
contraceptive,
provided
that
the
33
pharmacist
acts
reasonably
and
in
good
faith.
34
3.
The
board
shall
adopt
rules
pursuant
to
chapter
17A
to
35
-1-
LSB
2340HH
(4)
89
pf/rh
1/
7
H.F.
448
administer
this
section.
1
Sec.
3.
Section
514C.19,
Code
2021,
is
amended
to
read
as
2
follows:
3
514C.19
Prescription
contraceptive
coverage.
4
1.
Notwithstanding
the
uniformity
of
treatment
requirements
5
of
section
514C.6
,
a
group
policy
,
or
contract
,
or
plan
6
providing
for
third-party
payment
or
prepayment
of
health
or
7
medical
expenses
shall
not
do
either
of
the
following
comply
8
as
follows
:
9
a.
Exclude
Such
policy,
contract,
or
plan
shall
not
10
exclude
or
restrict
benefits
for
prescription
contraceptive
11
drugs
or
prescription
contraceptive
devices
which
prevent
12
conception
and
which
are
approved
by
the
United
States
13
food
and
drug
administration,
or
generic
equivalents
14
approved
as
substitutable
by
the
United
States
food
and
15
drug
administration,
if
such
policy
,
or
contract
,
or
plan
16
provides
benefits
for
other
outpatient
prescription
drugs
17
or
devices.
However,
such
policy,
contract,
or
plan
shall
18
specifically
provide
for
payment
for
a
self-administered
19
hormonal
contraceptive,
as
prescribed
by
a
practitioner
as
20
defined
in
section
155A.3,
and
dispensed
by
a
pharmacist
21
pursuant
to
section
155A.47,
including
payment
for
up
to
22
an
initial
three-month
supply
of
the
self-administered
23
hormonal
contraceptive
dispensed
at
one
time
and
for
up
to
a
24
twelve-month
supply
of
the
same
self-administered
hormonal
25
contraceptive
subsequently
dispensed
at
one
time.
26
b.
Exclude
Such
policy,
contract,
or
plan
shall
not
exclude
27
or
restrict
benefits
for
outpatient
contraceptive
services
28
which
are
provided
for
the
purpose
of
preventing
conception
if
29
such
policy
,
or
contract
,
or
plan
provides
benefits
for
other
30
outpatient
services
provided
by
a
health
care
professional.
31
2.
A
person
who
provides
a
group
policy
,
or
contract
,
or
32
plan
providing
for
third-party
payment
or
prepayment
of
health
33
or
medical
expenses
which
is
subject
to
subsection
1
shall
not
34
do
any
of
the
following:
35
-2-
LSB
2340HH
(4)
89
pf/rh
2/
7
H.F.
448
a.
Deny
to
an
individual
eligibility,
or
continued
1
eligibility,
to
enroll
in
or
to
renew
coverage
under
the
terms
2
of
the
policy
,
or
contract
,
or
plan
because
of
the
individual’s
3
use
or
potential
use
of
such
prescription
contraceptive
drugs
4
or
devices,
or
use
or
potential
use
of
outpatient
contraceptive
5
services.
6
b.
Provide
a
monetary
payment
or
rebate
to
a
covered
7
individual
to
encourage
such
individual
to
accept
less
than
the
8
minimum
benefits
provided
for
under
subsection
1
.
9
c.
Penalize
or
otherwise
reduce
or
limit
the
reimbursement
10
of
a
health
care
professional
because
such
professional
11
prescribes
contraceptive
drugs
or
devices,
or
provides
12
contraceptive
services.
13
d.
Provide
incentives,
monetary
or
otherwise,
to
a
health
14
care
professional
to
induce
such
professional
to
withhold
15
from
a
covered
individual
contraceptive
drugs
or
devices,
or
16
contraceptive
services.
17
3.
This
section
shall
not
be
construed
to
prevent
a
18
third-party
payor
from
including
deductibles,
coinsurance,
or
19
copayments
under
the
policy
,
or
contract,
or
plan
as
follows:
20
a.
A
deductible,
coinsurance,
or
copayment
for
benefits
21
for
prescription
contraceptive
drugs
shall
not
be
greater
than
22
such
deductible,
coinsurance,
or
copayment
for
any
outpatient
23
prescription
drug
for
which
coverage
under
the
policy
,
or
24
contract
,
or
plan
is
provided.
25
b.
A
deductible,
coinsurance,
or
copayment
for
benefits
for
26
prescription
contraceptive
devices
shall
not
be
greater
than
27
such
deductible,
coinsurance,
or
copayment
for
any
outpatient
28
prescription
device
for
which
coverage
under
the
policy
,
or
29
contract
,
or
plan
is
provided.
30
c.
A
deductible,
coinsurance,
or
copayment
for
benefits
for
31
outpatient
contraceptive
services
shall
not
be
greater
than
32
such
deductible,
coinsurance,
or
copayment
for
any
outpatient
33
health
care
services
for
which
coverage
under
the
policy
,
or
34
contract
,
or
plan
is
provided.
35
-3-
LSB
2340HH
(4)
89
pf/rh
3/
7
H.F.
448
4.
This
section
shall
not
be
construed
to
require
a
1
third-party
payor
under
a
policy
,
or
contract
,
or
plan
2
to
provide
benefits
for
experimental
or
investigational
3
contraceptive
drugs
or
devices,
or
experimental
or
4
investigational
contraceptive
services,
except
to
the
extent
5
that
such
policy
,
or
contract
,
or
plan
provides
coverage
for
6
other
experimental
or
investigational
outpatient
prescription
7
drugs
or
devices,
or
experimental
or
investigational
outpatient
8
health
care
services.
9
5.
This
section
shall
not
be
construed
to
limit
or
otherwise
10
discourage
the
use
of
generic
equivalent
drugs
approved
by
the
11
United
States
food
and
drug
administration,
whenever
available
12
and
appropriate.
This
section
,
when
a
brand
name
drug
is
13
requested
by
a
covered
individual
and
a
suitable
generic
14
equivalent
is
available
and
appropriate,
shall
not
be
construed
15
to
prohibit
a
third-party
payor
from
requiring
the
covered
16
individual
to
pay
a
deductible,
coinsurance,
or
copayment
17
consistent
with
subsection
3
,
in
addition
to
the
difference
of
18
the
cost
of
the
brand
name
drug
less
the
maximum
covered
amount
19
for
a
generic
equivalent.
20
6.
A
person
who
provides
an
individual
policy
,
or
contract
,
21
or
plan
providing
for
third-party
payment
or
prepayment
of
22
health
or
medical
expenses
shall
make
available
a
coverage
23
provision
that
satisfies
the
requirements
in
subsections
24
1
through
5
in
the
same
manner
as
such
requirements
are
25
applicable
to
a
group
policy
,
or
contract
,
or
plan
under
those
26
subsections.
The
policy
,
or
contract
,
or
plan
shall
provide
27
that
the
individual
policyholder
may
reject
the
coverage
28
provision
at
the
option
of
the
policyholder.
29
7.
a.
This
section
applies
to
the
following
classes
of
30
third-party
payment
provider
contracts
,
or
policies
,
or
plans
31
delivered,
issued
for
delivery,
continued,
or
renewed
in
this
32
state
on
or
after
July
1,
2000
January
1,
2022
:
33
(1)
Individual
or
group
accident
and
sickness
insurance
34
providing
coverage
on
an
expense-incurred
basis.
35
-4-
LSB
2340HH
(4)
89
pf/rh
4/
7
H.F.
448
(2)
An
individual
or
group
hospital
or
medical
service
1
contract
issued
pursuant
to
chapter
509
,
514
,
or
514A
.
2
(3)
An
individual
or
group
health
maintenance
organization
3
contract
regulated
under
chapter
514B
.
4
(4)
Any
other
entity
engaged
in
the
business
of
insurance,
5
risk
transfer,
or
risk
retention,
which
is
subject
to
the
6
jurisdiction
of
the
commissioner.
7
(5)
A
plan
established
pursuant
to
chapter
509A
for
public
8
employees.
9
b.
This
section
shall
not
apply
to
accident-only,
10
specified
disease,
short-term
hospital
or
medical,
hospital
11
confinement
indemnity,
credit,
dental,
vision,
Medicare
12
supplement,
long-term
care,
basic
hospital
and
medical-surgical
13
expense
coverage
as
defined
by
the
commissioner,
disability
14
income
insurance
coverage,
coverage
issued
as
a
supplement
15
to
liability
insurance,
workers’
compensation
or
similar
16
insurance,
or
automobile
medical
payment
insurance.
17
8.
This
section
shall
not
be
construed
to
require
a
18
third-party
payor
to
provide
payment
to
a
practitioner
for
the
19
dispensing
of
a
self-administered
hormonal
contraceptive
to
20
replace
a
self-administered
hormonal
contraceptive
that
has
21
been
dispensed
to
a
covered
person
and
that
has
been
misplaced,
22
stolen,
or
destroyed.
This
section
shall
not
be
construed
to
23
require
a
third-party
payor
to
replace
covered
prescriptions
24
that
are
misplaced,
stolen,
or
destroyed.
25
9.
For
the
purposes
of
this
section,
“self-administered
26
hormonal
contraceptive”
means
a
self-administered
hormonal
27
contraceptive
that
is
approved
by
the
United
States
food
and
28
drug
administration
to
prevent
pregnancy.
29
EXPLANATION
30
The
inclusion
of
this
explanation
does
not
constitute
agreement
with
31
the
explanation’s
substance
by
the
members
of
the
general
assembly.
32
This
bill
relates
to
the
dispensing
of
self-administered
33
hormonal
contraceptives.
34
The
bill
provides
definitions
of
“generic”
and
35
-5-
LSB
2340HH
(4)
89
pf/rh
5/
7
H.F.
448
“self-administered
hormonal
contraceptive”
for
the
purposes
of
1
the
bill.
2
The
bill
provides
that
notwithstanding
any
provision
of
law
3
to
the
contrary,
a
pharmacist
may
dispense
a
self-administered
4
hormonal
contraceptive
to
a
patient
pursuant
to
a
prescription
5
based
upon
whether
the
dispensing
is
an
initial
or
subsequent
6
dispensing.
If
the
dispensing
is
the
initial
dispensing
of
7
a
self-administered
hormonal
contraceptive,
the
pharmacist
8
may
dispense
only
up
to
a
three-month
supply
at
one
time.
9
If
the
dispensing
is
a
subsequent
dispensing
of
the
same
10
self-administered
hormonal
contraceptive,
the
pharmacist
may
11
dispense
up
to
a
12-month
supply
at
one
time.
Subsequent
12
dispensing
of
the
same
self-administered
hormonal
contraceptive
13
includes
the
subsequent
dispensing
of
a
generic
form
of
14
self-administered
hormonal
contraceptive
in
place
of
a
15
brand-name
self-administered
hormonal
contraceptive.
16
A
pharmacist
who
dispenses
a
self-administered
hormonal
17
contraceptive
in
compliance
with
the
bill
shall
be
immune
from
18
criminal
and
civil
liability
arising
from
any
damages
caused
by
19
the
dispensing,
administering,
or
use
of
a
self-administered
20
hormonal
contraceptive,
provided
that
the
pharmacist
acts
21
reasonably
and
in
good
faith.
The
board
of
pharmacy
shall
22
adopt
administrative
rules
to
administer
the
bill.
23
The
bill
also
requires
a
group
policy,
contract,
or
plan
24
providing
for
third-party
payment
or
prepayment
of
health
or
25
medical
expenses
to
specifically
provide,
in
any
contract,
26
policy,
or
plan
delivered,
issued
for
delivery,
continued,
27
or
renewed
in
this
state
on
or
after
January
1,
2022,
for
28
payment
for
a
self-administered
hormonal
contraceptive,
as
29
prescribed
by
a
practitioner
and
dispensed
by
a
pharmacist
30
pursuant
to
the
bill,
including
payment
for
up
to
an
initial
31
three-month
supply
of
the
self-administered
hormonal
32
contraceptive
dispensed
at
one
time
and
for
up
to
a
12-month
33
supply
of
the
same
self-administered
hormonal
contraceptive
34
subsequently
dispensed
at
one
time.
This
requirement
is
not
to
35
-6-
LSB
2340HH
(4)
89
pf/rh
6/
7
H.F.
448
be
construed
to
require
a
third-party
payor
to
provide
payment
1
to
a
practitioner
for
the
dispensing
of
a
self-administered
2
hormonal
contraceptive
to
replace
a
self-administered
3
hormonal
contraceptive
that
has
been
dispensed
to
a
covered
4
person
and
that
has
been
misplaced,
stolen,
or
destroyed.
5
This
requirement
also
shall
not
be
construed
to
require
a
6
third-party
payor
to
replace
covered
prescriptions
that
are
7
misplaced,
stolen,
or
destroyed.
8
-7-
LSB
2340HH
(4)
89
pf/rh
7/
7